The National Capital Chapter is fortunate to have several premiere medical and research institutions in our area. Many of them run local MS studies or drug trials. Without people living with MS who are willing to serve as volunteers in these studies, we could not look forward to new and better therapies.
Current Local Studies/Trials in Need of Participants
The MS Aquatics Research Study
The MS Aquatics Research Study is seeking participants with multiple sclerosis for a study on the benefits of and barriers to participation in an aquatics program. Study participation involves a one hour (approximate) telephone interview that explores:
- Aquatics program experiences
- Exercise beliefs
- Fatigue level and overall health
If you have participated in an aquatics program within the past six months and would like to contribute to the findings of this study please use the contact information below.
Participants who complete the telephone interview will receive a $25 gift card from a national retailer in appreciation of their time.
The MS Aquatics Research Study is funded by the National Multiple Sclerosis Society and has been approved by the UMBC Institutional Review Board (IRB), number Y09SC21217
Contact Information: Dr. Sarah Chard, Ph.D., from the Department of Sociology and Anthropology at the University of Maryland, Baltimore County, at 410-455-1632 for further information or to arrange the telephone interview.
NIH Study of Primary Progressive Multiple Sclerosis
The Neuroimmunology Branch (NIB) of the National Institutes of Health is conducting a study to investigate the efficacy of an oral experimental drug in primary progressive multiple sclerosis.
Inclusion Criteria: Participants ages 18-55 who have a diagnosis of Primary Progressive Multiple Sclerosis and are not taking any immunomodulatory drugs.
Location: The study will be conducted at the NIH Clinical Center in Bethesda, Md., on an outpatient basis.
Contact information: Call (301) 496-0064
View a flyer for this study.
TYSABRI(r) Global Observational Program in Safety (TYGRIS)
A safety observational cohort program designed to obtain long-term safety data in multiple sclerosis (MS) patients treated with TYSABRI(r) in a clinical practice setting in the United States or Canada.
Inclusion Criteria: MS patients in the US and Canada receiving TYSABRI(r) under standard clinical care for less than or equal to 3 infusions are eligible to participate in TYGRIS.
Institution/Location: George Washington University Medical Faculty Associates, Washington, DC
Contact Information: Tsega Mesfin MSHA, Clinical Research Coordinator, (202) 741-2717
Clinical Trial: High-dose cyclophosphamide
Description: Pilot study in aggressive MS
Institution/Location: Johns Hopkins University, Baltimore, Md.
Contact Information: Chitra Krishnan, (410) 955-3129
For more information, call (202) 296-5363.
Search for Clinical Trials nationwide.
Find online surveys and studies.